CY1115781T1 - MODIFIED erythropoietin - Google Patents

MODIFIED erythropoietin

Info

Publication number
CY1115781T1
CY1115781T1 CY20141100978T CY141100978T CY1115781T1 CY 1115781 T1 CY1115781 T1 CY 1115781T1 CY 20141100978 T CY20141100978 T CY 20141100978T CY 141100978 T CY141100978 T CY 141100978T CY 1115781 T1 CY1115781 T1 CY 1115781T1
Authority
CY
Cyprus
Prior art keywords
erythropoietin
relates
modified erythropoietin
present
pegylated
Prior art date
Application number
CY20141100978T
Other languages
Greek (el)
Inventor
Abraham Abuchowski
Lihysyng Stanford Lee
Original Assignee
Prolong Pharmaceuticals, LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07812992.1A external-priority patent/EP2054074B8/en
Application filed by Prolong Pharmaceuticals, LLC filed Critical Prolong Pharmaceuticals, LLC
Publication of CY1115781T1 publication Critical patent/CY1115781T1/en

Links

Abstract

Η παρούσα εφεύρεση σχετίζεται σε νέα πρωτεϊνικά συζεύγματα, ειδικότερα, σε νέες πεγκυλιωμένες πρωτεΐνες, και στις μεθόδους παρασκευής και χρήσης τους. Μια άποψη της παρούσας εφεύρεσης σχετίζεται με πεγκυλιωμένη ερυθροποιητίνη που έχει μεγαλύτερη κλινική αποτελεσματικότητα και σταθερότητα κατά τη μεταφορά και την αποθήκευση σε σχέση με τα σημερινά σκευάσματα ερυθροποιητίνης.The present invention relates to novel protein conjugates, in particular, to new pegylated proteins, and to methods for their preparation and use. One aspect of the present invention relates to pegylated erythropoietin having greater clinical efficacy and stability in transport and storage than current erythropoietin formulations.

CY20141100978T 2006-08-04 2014-11-26 MODIFIED erythropoietin CY1115781T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83542906A 2006-08-04 2006-08-04
EP07812992.1A EP2054074B8 (en) 2006-08-04 2007-07-16 Modified erythropoietin

Publications (1)

Publication Number Publication Date
CY1115781T1 true CY1115781T1 (en) 2017-01-25

Family

ID=58457278

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100978T CY1115781T1 (en) 2006-08-04 2014-11-26 MODIFIED erythropoietin

Country Status (1)

Country Link
CY (1) CY1115781T1 (en)

Similar Documents

Publication Publication Date Title
CY1121687T1 (en) AMINO ACID SEQUENCES TARGETING ENVELOPE PROTEINS OF AN IOY AND POLYPEPTIDES CONTAINING THEM FOR THE THERAPEUTIC TREATMENT OF VIRAL DISEASES
CY1124844T1 (en) PHARMACEUTICAL ANTIBODY PREPARATION
CY1119265T1 (en) CONSTRUCTION OF TRIANGLE ANTI-HUMAN RESPIRATORY SYNCHRONIC VIRUS (HRSV) FOR PREVENTION AND / OR TREATMENT OF INFECTIOUS INFECTIONS
CY1118243T1 (en) NEW TRANSPORT CONTAINERS AND LOAD TRANSPORT CONTAINER PARTS
CY1124802T1 (en) SCLEROSTEIN BINDING FACTORS
CY1120994T1 (en) INNOVATIVE SOLUTION COMPOSITIONS CONTAINING CELLULAR AGENTS AND USING THEM FOR WOUND TREATMENT
CY1119243T1 (en) VEGF COMPONENT PHARMACEUTICAL FORMS
CY1121632T1 (en) RV2386C TUBERCULOSIS PROTEIN, ITS COMPOSITIONS AND USES
CY1117401T1 (en) ALBUMIN Fusion Proteins
CY1117162T1 (en) METHOD OF CONSTRUCTION OF FC-CATHERMAL PARTICULAR PARTS USING ELECTROSTATIC GUIDELINES
EA201391632A1 (en) AMINO ACID SEQUENCES ARE DIRECTED AGAINST IL-17A, IL-17F AND / OR IL-17A / F AND CONTAINING THEIR POLYPEPTIDES
CY1112682T1 (en) Active IL-18 Protein Conjugates and their Medical Uses
CY1119979T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TOXIDE A AND B TOY CLOSTRIDIUM DIFFICILE
CY1113267T1 (en) SULFUR PRODUCTS AS S1P1 / EDG1 BACKGROUND AGENTS
CY1115082T1 (en) Substituted 1,3-bisphenylpropane derivatives, preparations and their uses
CY1116011T1 (en) HLA-A * 1101-LIMITED WT1 PIPE AND PHARMACEUTICAL COMPOSITION INCLUDING IT
CY1121742T1 (en) S100A4 ANTIBODIES AND THERAPEUTIC USES THEREOF
EA201171494A1 (en) MIMETIC PROTEINS SMAC
CY1113819T1 (en) PRECAUTIONS FOR CANCER TREATMENT
CY1114626T1 (en) CYCLOTHYLENE GLYCOLOGY METHODS AND PROTEINS / Peptides Produced By These Methods
CY1116482T1 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF TUMOR, INFOSES, AND PULMONARY CELL PROTEINS
CY1112924T1 (en) JNK Cell Signaling Disruptions
CY1114504T1 (en) TIGECYCLINE COMPOSITIONS AND PREPARATION METHODS
CY1108306T1 (en) MTP AND APOB AJAIDOLO Suspensions
CY1110177T1 (en) Z-CARBONYLSYL SUBSTITUTED BISINSULARS AS RAF MOTION INHIBITORS